Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OBS Pharma is a leading pharmaceutical company based in Pakistan and a core entity within the OBS Group. The company specializes in the manufacturing, marketing, and distribution of a diverse portfolio of pharmaceutical products across specialized therapeutic areas, including cardiology, endocrinology, gastroenterology, and women's health. OBS Pharma established its market prominence through the strategic acquisition of Organon's business operations in Pakistan and continues to maintain robust alliances with global pharmaceutical leaders such as Merck & Co. (MSD), Vifor Pharma, and Santen. The company operates state-of-the-art manufacturing facilities that comply with international quality standards, ensuring the delivery of high-quality healthcare solutions to the regional market. With a strong distribution network and a focus on specialized medicine, OBS Pharma is positioned as one of the top pharmaceutical players in South Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OBS Pharma.